Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SRC inhibitors(Tyrosine-protein kinase SRC inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H26BrClN6OS |
InChIKeyTWWILBWAYDXBCM-UHFFFAOYSA-N |
CAS Registry1640012-88-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Preclinical | IT | 11 May 2016 |